Regeneron Pharmaceuticals' Non-cash Items fell 550.57% to $326.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $474.0 million, marking a year-over-year increase of 590000.0%. This contributed to the annual value of $474.0 million for FY2025, which is 590000.0% up from last year.
As of Q4 2025, Regeneron Pharmaceuticals' Non-cash Items stood at $326.1 million, which was down 550.57% from $158.7 million recorded in Q3 2025.
In the past 5 years, Regeneron Pharmaceuticals' Non-cash Items ranged from a high of $1.8 billion in Q3 2021 and a low of -$2.5 billion during Q2 2021
Its 5-year average for Non-cash Items is $40.2 million, with a median of $125.0 million in 2021.
As far as peak fluctuations go, Regeneron Pharmaceuticals' Non-cash Items plummeted by 546268.98% in 2021, and later surged by 59370.53% in 2024.
Over the past 5 years, Regeneron Pharmaceuticals' Non-cash Items (Quarter) stood at $143.5 million in 2021, then surged by 264.32% to $522.8 million in 2022, then plummeted by 113.37% to -$69.9 million in 2023, then skyrocketed by 593.71% to $345.1 million in 2024, then decreased by 5.51% to $326.1 million in 2025.
Its Non-cash Items was $326.1 million in Q4 2025, compared to $158.7 million in Q3 2025 and -$247.2 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value